Ethnic and racial minorities are commonly underrepresented in clinical trials. This problem is so severe that in April, the U.S. Food and Drug Administration (FDA) expanded upon existing guidance to further emphasize recommendations to sponsors developing treatments to increase enrollment from underrepresented populations in the U.S., including African-American, Hispanic, Asian and other persons of color, in clinical trials. In the updated guidance, the FDA provided details on what sponsors
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
How Virtual-First Clinical Trials Scale Access for Participants
Making clinical trials equitable is one of the biggest challenges we face as an industry. We see this time and again, with one of the latest examples coming in the form of a study published in JAMA Network Open that found substantial underrepresentation of Black patients enrolled in pivotal trials for CAR-T therapy.
Women are another demographic negatively affected by inequality in clinical research. Earlier this month [May 2022] the American Heart Association issued a
Read More
AI Improving the Patient Experience of Cancer Care
For cancer patients and their loved ones, days, weeks, and months matter. In fact, anyone who has waited anxiously for test results or a treatment regimen to begin can attest that hours, or even minutes, will drag on with emotional heaviness. From a clinical standpoint as well, time to treatment significantly impacts outcomes. All suspected cancers should be ruled out or confirmed with a diagnosis so treatment can begin as soon as possible. Similarly, patients with incidental findings—masses or
Read More
Why Preventive Healthcare Hinges on Diagnostics Innovation
There is a real sense that we are on the cusp of a diagnostics revolution. This has been spurred on by the pandemic, which at once underscored the tremendous power of mass testing as it became the fundamental basis for decision-making, from our own personal health to national policy. It also revealed gaps in terms of needing to drastically scale up testing capacity and invest in new and innovative digital diagnostics tools.
Innovation in diagnostics, however, is
Read More
Site Enablement Platforms Can Accelerate Clinical Trials by 6 Weeks and Reduce Costs by Over $1M
What You Should Know:
- Florence HealthcareTM, a clinical research technology company headquartered in Atlanta, Georgia, recently announced the completion of a year-long third-party study on the impact of Site Enablement PlatformsTM on clinical research timelines and costs.
- The study by Marketcap Consulting is the first to compare how traditional site management approaches differ from site-first Site Enablement Platforms. The study looked at the impact of traditional sponsor
Read More
Evaluating Evidence Base in Digital Health Solutions: The Real Questions Stakeholders Should Be Asking
Throughout the pandemic, digital health companies have seen significant growth, with one study finding that U.S.-based digital health startups surpassed $29 billion in 2021, almost twice the funding seen in 2020. When done correctly, the use of these digital innovations can help people reduce the burden of dealing with mental health challenges by providing accessible, affordable, and timely care to users. As digital mental health interventions (DMHI) continue to battle it out for a leading spot
Read More
Vivalink Integrates with Garmin, Other Wearables to Address RPM Interoperability
What You Should Know:
- Vivalink is addressing these RPM interoperability challenges by announcing today that leading wearables and medical-grade devices are integrating with the company’s Biometrics Data Platform.
- Now, leading pulse oximeters, blood glucose monitors and sleep monitors by companies like Garmin and Roche are available alongside the Platform to accelerate development and deployment of novel healthcare applications and research.
Why It Matters
Integration and
Read More
Non-Invasive, Precision-Based Approaches for Diagnosis and Treatment of Inflammatory Skin Conditions
Inflammatory skin conditions such as atopic dermatitis, psoriasis, vitiligo, hidradenitis suppurativa and others impact a significant portion of the U.S. population. In fact, nearly half of all visits to primary care physicians include some level of dermatological indication. Many of these dermatologic conditions are accompanied by pain and severe discomfort for affected patients, and the resulting morbidity of the condition may have a negative impact on mental health, self-esteem and overall
Read More
The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank
Advanced medical research has brought us to the point where many serious conditions can potentially be treated and even cured - with people who have essentially faced a lifetime of being incapacitated finally able to conduct normal lives. Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. The latest example–and most expensive medication to date– is bluebird bio’s recently-approved $2.8 million gene therapy to treat a rare blood
Read More
HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others
Venture Capital, Private Equity Funding
Maven Clinic Secures $90M to Advance End-to-End Family Care Platform
Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere.
Curavit Raises $5M for Digital Therapeutics
Read More